Safety, efficacy, and clinical outcomes of transcatheter tricuspid valve replacement: One-year follow-up.

ABSTRACT:

Objective

The aim was to evaluate the safety and efficacy of TTVR in patients with severe TR at the 1-year follow-up.

Materials and methods

This project was a single-center, observational study. From September 2020 to May 2021, 15 patients with severe or extremely severe TR at high risk of traditional surgery were enrolled. All patients had preoperative imaging assessments to evaluate the tricuspid valve and the anatomy of the right heart. All patients were planned to treated with the LuX-Valve (Ningbo Jenscare Biotechnology, Ningbo, China). The LuX-Valve was implanted under the intraoperative guidance of TEE and X-ray fluoroscopy. Data were collected at baseline, before discharge, and at 30 days, 6 months, and 1 year postoperatively.

Results

The LuX-Valves were succe

SUBMITTER: Mao Y 

PROVIDER: S-EPMC9751353 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature